|
1
|
Sturm D, Witt H, Hovestadt V, Khuong-Quang
DA, Jones DTW, Konermann C, Pfaff E, Tönjes M, Sill M, Bender S, et
al: Hotspot mutations in H3F3A and IDH1 define distinct epigenetic
and biological subgroups of glioblastoma. Cancer Cell. 22:425–437.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Strichman-Almashanu LZ, Lee RS, Onyango
PO, Perlman E, Flam F, Frieman MB and Feinberg AP: A genome-wide
screen for normally methylated human CpG islands that can identify
novel imprinted genes. Genome Res. 12:543–554. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gill RM, Hamel PA, Zhe J, Zacksenhaus E,
Gallie BL and Phillips RA: Characterization of the human RB1
promoter and of elements involved in transcriptional regulation.
Cell Growth Differ. 5:467–474. 1994.PubMed/NCBI
|
|
4
|
Wu H and Zhang Y: Reversing DNA
methylation: Mechanisms, genomics, and biological functions. Cell.
156:45–68. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sparkes RS, Murphree AL, Lingua RW,
Sparkes MC, Field LL, Funderburk SJ and Benedict WF: Gene for
hereditary retinoblastoma assigned to human chromosome 13 by
linkage to esterase D. Science. 219:971–973. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sellers WR and Kaelin WG Jr: Role of the
retinoblastoma protein in the pathogenesis of human cancer. J Clin
Oncol. 15:3301–3312. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sherr CJ and Roberts JM: CDK inhibitors:
Positive and negative regulators of G1-phase progression. Genes
Dev. 13:1501–1512. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Buchkovich K, Duffy LA and Harlow E: The
retinoblastoma protein is phosphorylated during specific phases of
the cell cycle. Cell. 58:1097–1105. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Khani P, Nasri F, Khani Chamani F, Saeidi
F, Sadri Nahand J, Tabibkhooei A and Mirzaei H: Genetic and
epigenetic contribution to astrocytic gliomas pathogenesis. J
Neurochem. 148:188–203. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Henson JW, Schnitker BL, Correa KM, von
Deimling A, Fassbender F, Xu HJ, Benedict WF, Yandell DW and Louis
DN: The retinoblastoma gene is involved in malignant progression of
astrocytomas. Ann Neurol. 36:714–721. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ruas M and Peters G: The p16INK4a/CDKN2A
tumor suppressor and its relatives. Biochim Biophys Acta.
1378:F115–F177. 1998.PubMed/NCBI
|
|
12
|
Ueki K, Ono Y, Henson JW, Efird JT, von
Deimling A and Louis DN: CDKN2/p16 or RB alterations occur in the
majority of glioblastomas and are inversely correlated. Cancer Res.
56:150–153. 1996.PubMed/NCBI
|
|
13
|
Ichimura K, Schmidt EE, Goike HM and
Collins VP: Human glioblastomas with no alterations of the CDKN2A
(p16INK4A, MTS1) and CDK4 genes have frequent mutations of the
retinoblastoma gene. Oncogene. 13:1065–1072. 1996.PubMed/NCBI
|
|
14
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 World Health Organization
classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Müllenbach R, Lagoda PJ and Welter C: An
efficient salt-chloroform extraction of DNA from blood and tissues.
Trends Genet. 5:3911989.PubMed/NCBI
|
|
16
|
Herman JG, Graff JR, Myöhänen S, Nelkin BD
and Baylin SB: Methylation-specific PCR: A novel PCR assay for
methylation status of CpG islands. Proc Natl Acad Sci USA.
93:9821–9826. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
van Tilborg AA, Morolli B, Giphart-Gassler
M, de Vries A, van Geenen DA, Lurkin I, Kros JM and Zwarthoff EC:
Lack of genetic and epigenetic changes in meningiomas without NF2
loss. J Pathol. 208:564–573. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Simpson DJ, Hibberts NA, McNicol AM,
Clayton RN and Farrell WE: Loss of pRb expression in pituitary
adenomas is associated with methylation of the RB1 CpG island.
Cancer Res. 60:1211–1216. 2000.PubMed/NCBI
|
|
19
|
Esteller M, Garcia-Foncillas J, Andion E,
Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB and Herman JG:
Inactivation of the DNA-repair gene MGMT and the clinical response
of gliomas to alkylating agents. N Engl J Med. 343:1350–1354. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hegi ME, Diserens AC, Gorlia T, Hamou MF,
de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani
L, et al: MGMT gene silencing and benefit from temozolomide in
glioblastoma. N Engl J Med. 352:997–1003. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Karnofsky Performance Status-an overview |
ScienceDirect Topics [Internet]. [zitiert 8. August 2022].
Available from. https://www.sciencedirect.com/topics/nursing–and–
health–professions/karnofsky–performance-status
|
|
22
|
Schiff D, Lee EQ, Nayak L, Norden AD,
Reardon DA and Wen PY: Medical management of brain tumors and the
sequelae of treatment. Neuro Oncol. 17:488–504. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
J Dabrowski M and Wojtas B: Global DNA
methylation patterns in human gliomas and their interplay with
other epigenetic modifications. Int J Mol Sci. 20:34782019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Taylor KH, Kramer RS, Davis JW, Guo J,
Duff DJ, Xu D, Caldwell CW and Shi H: Ultradeep bisulfite
sequencing analysis of DNA methylation patterns in multiple gene
promoters by 454 sequencing. Cancer Res. 67:8511–8518. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Raineri S and Mellor J: IDH1: Linking
metabolism and epigenetics. Front Genet. 9:4932018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chinnam M and Goodrich DW: RB1,
development, and cancer. Curr Top Dev Biol. 94:129–169. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Indovina P, Pentimalli F, Casini N, Vocca
I and Giordano A: RB1 dual role in proliferation and apoptosis:
Cell fate control and implications for cancer therapy. Oncotarget.
6:17873–17890. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Aubrey BJ, Kelly GL, Janic A, Herold MJ
and Strasser A: How does p53 induce apoptosis and how does this
relate to p53-mediated tumour suppression? Cell Death Differ.
25:104–113. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nakamura M, Yonekawa Y, Kleihues P and
Ohgaki H: Promoter hypermethylation of the RB1 gene in
glioblastomas. Lab Invest. 81:77–82. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gonzalez-Gomez P, Bello MJ, Alonso ME,
Arjona D, Lomas J, de Campos JM, Isla A and Rey JA: CpG island
methylation status and mutation analysis of the RB1 gene essential
promoter region and protein-binding pocket domain in nervous system
tumours. Br J Cancer. 88:109–114. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yin D, Xie D, Hofmann WK, Miller CW, Black
KL and Koeffler HP: Methylation, expression, and mutation analysis
of the cell cycle control genes in human brain tumors. Oncogene.
21:8372–8378. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yu J, Zhang H, Gu J, Lin S, Li J, Lu W,
Wang Y and Zhu J: Methylation profiles of thirty four promoter-CpG
islands and concordant methylation behaviours of sixteen genes that
may contribute to carcinogenesis of astrocytoma. BMC Cancer.
4:652004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ohta T, Watanabe T, Katayama Y, Yoshino A,
Yachi K, Ogino A, Komine C and Fukushima T: Aberrant promoter
hypermethylation profile of cell cycle regulatory genes in
malignant astrocytomas. Oncol Rep. 16:957–963. 2006.PubMed/NCBI
|
|
35
|
Ferreira WAS, Araújo MD, Anselmo NP, de
Oliveira EHC, Brito JRN, Burbano RR, Harada ML and Borges Bdo N:
Expression analysis of genes involved in the RB/E2F pathway in
astrocytic tumors. PLoS One. 10:e01372592015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li Y and Tollefsbol TO: DNA methylation
detection: Bisulfite genomic sequencing analysis. Methods Mol Biol.
791:11–21. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Suwala AK, Stichel D, Schrimpf D, Maas
SLN, Sill M, Dohmen H, Banan R, Reinhardt A, Sievers P, Hinz F, et
al: Glioblastomas with primitive neuronal component harbor a
distinct methylation and copy-number profile with inactivation of
TP53, PTEN, and RB1. Acta Neuropathol. 142:179–189. 2021.
View Article : Google Scholar : PubMed/NCBI
|
